Family Psychiatry Services - Medicare Mental Health Clinic in Orange City, FL

Family Psychiatry Services is a medicare enrolled mental health clinic (Community/behavioral Health) in Orange City, Florida. The current practice location for Family Psychiatry Services is 2725 Rebecca Ln Ste 107, Orange City, Florida. For appointments, you can reach them via phone at (386) 775-0736. The mailing address for Family Psychiatry Services is 2725 Rebecca Ln Ste 107, Orange City, Florida and phone number is (386) 775-0736.

Family Psychiatry Services is licensed to practice in Florida (license number ). The clinic also participates in the medicare program and its NPI number is 1417018482. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (386) 775-0736.

Contact Information

Family Psychiatry Services
2725 Rebecca Ln Ste 107
Orange City
FL 32763-8350
(386) 775-0736
(386) 775-0738

Mental Health Clinic Profile

Full NameFamily Psychiatry Services
SpecialityCommunity/Behavioral Health
Location2725 Rebecca Ln Ste 107, Orange City, Florida
Authorized Official Name and PositionAdly Thebaud (OWNER)
Authorized Official Contact3867750736
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Family Psychiatry Services
2725 Rebecca Ln Ste 107
Orange City
FL 32763-8350

Ph: (386) 775-0736
Family Psychiatry Services
2725 Rebecca Ln Ste 107
Orange City
FL 32763-8350

Ph: (386) 775-0736

NPI Details:

NPI Number1417018482
Provider Enumeration Date12/13/2006
Last Update Date11/09/2023
Certification Date11/09/2023

Medicare PECOS Information:

Medicare PECOS PAC ID0143270579
Medicare Enrollment IDO20050124001039

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Family Psychiatry Services such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1417018482NPI-NPPES
K0231OtherFLMEDICARE
010364600MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0804XPsychiatry & Neurology - Child & Adolescent Psychiatry ME60436 (Florida)Secondary
251S00000XCommunity/behavioral Health (Florida)Primary
363LP0808XNurse Practitioner - Psychiatric/mental Health ARNP 9231203 (Florida)Secondary
363LP0808XNurse Practitioner - Psychiatric/mental Health ARNP 9410846 (Florida)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Family Psychiatry Services acts as a billing entity for following providers:
Provider NameN Kelly Speranzo Otero
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679797856
PECOS PAC ID: 1052331881
Enrollment ID: I20051123000054

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

Provider NameAdly Thebaud
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1629049770
PECOS PAC ID: 5597715920
Enrollment ID: I20110406000825

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

Provider NameJosette Romain
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1851408348
PECOS PAC ID: 0042488173
Enrollment ID: I20110715000516

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

Provider NameFhteachia Michelle Andrews
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1366854598
PECOS PAC ID: 4789803750
Enrollment ID: I20180605001214

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

Provider NameCheryl Adkinson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013658137
PECOS PAC ID: 0547649980
Enrollment ID: I20220615002128

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

Provider NameJessica K Shutt
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1700052214
PECOS PAC ID: 7315016201
Enrollment ID: I20231113001538

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more Medical News

› Verified 9 days ago

News Archive

Boehringer Ingelheim selects Veeva as global CRM provider

Boehringer Ingelheim, a Top 20 global pharmaceutical company has selected Veeva CRM, including iRep for the iPad, for global deployment supporting its prescription medicine commercial and medical teams.

New study uncovers 3D structure of toxin responsible for C. diff infection

A new study, led by researchers from the University of California, Irvine, uncovers the long-sought-after, three-dimensional structure of a toxin primarily responsible for devastating Clostridium difficile infection.

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

Multimechanism-targeted therapy for migraine more effective than single medications

Combining two different types of treatment for migraine results in better symptom relief than taking either one of the medications, according to a study in the April 4 issue of JAMA.

Scientists discover biological fingerprint in children with tuberculosis meningitis

Children with tuberculosis meningitis - a brain and spinal cord infection that leads to disability and death - have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments, scientists at the Francis Crick Institute, Imperial College London and the University of Cape Town reveal.

Read more News

› Verified 9 days ago

Community/Behavioral Health in Orange City, FL

Cln Therapeutic Solutions
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 366 E Graves Ave Ste D, Orange City, FL 32763
Phone: 801-450-5704    Fax: 386-561-9974
Nudawn Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1610 14th St, Orange City, FL 32763
Phone: 352-379-2829    Fax: 352-379-2843
Rising Phoenix Counseling, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 366 E Graves Ave Ste D, Orange City, FL 32763
Phone: 407-777-2596    
Awareness Counseling Center
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2425 S Volusia Ave, Suite B-4, Orange City, FL 32763
Phone: 386-774-1330    Fax: 888-808-2088
Coastal Mental Health Center Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 300 Treemonte Dr, Orange City, FL 32763
Phone: 800-614-4124    Fax: 888-217-4124
Insights Counseling Center, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2425 S Volusia Ave, Suite B2, Orange City, FL 32763
Phone: 386-848-5170    Fax: 386-740-8251
Fish Family And Associates
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2425 S Volusia Ave, Suite #b2, Orange City, FL 32763
Phone: 386-456-0008    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.